Latest Breaking News On - Fennec pharmaceuticals inc - Page 5 : comparemela.com

Fennec Pharmaceuticals Inc (NASDAQ:FENC) COO Sells $220,220.02 in Stock

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Sells 40,584 Shares of Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) CEO Rosty Raykov sold 40,584 shares of the business’s stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average price of $10.78, for a total transaction of $437,495.52. Following the completion of the sale, the chief executive officer now owns 276,054 shares […]

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Sells $437,495.52 in Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) CEO Rosty Raykov sold 40,584 shares of the stock in a transaction on Wednesday, April 3rd. The shares were sold at an average price of $10.78, for a total transaction of $437,495.52. Following the completion of the sale, the chief executive officer now directly owns 276,054 shares […]

HC Wainwright Comments on Fennec Pharmaceuticals Inc's Q2 2024 Earnings (NASDAQ:FENC)

Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)

Fennec Pharmaceuticals Inc (NASDAQ:FENC), a biopharmaceutical company focused on the development of PEDMARK for the prevention of platinum-induced ototoxicity in pediatric cancer patients, has reported a significant insider sell transaction.